ArticleCell death & disease2024

Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer.

Chih-Chieh Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.